Amanta Healthcare Limited

About

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering with various foreign and Indian pharmaceutical companies. Amanta Healthcare Limited was formerly known as Marck Biosciences Limited and changed its name to Amanta Healthcare Limited in June 2014. Amanta Healthcare Limited was incorporated in 1994 and is headquartered in Ahmedabad, India.

Key Metrics

as of Sep 2026

Market Cap753 Cr

P/E49.10

Div Yield0.00 %

Book Value₹56.70

52w High₹206.00

52w Low₹92.00

Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Sales	68.80	76.99	74.49	70.89	65.31	72.06	67.81	66.73	68.10
Expenses	54.26	62.03	59.13	56.24	50.41	53.10	52.75	52.85	54.70
Operating Profit	14.54	14.96	15.36	14.65	14.90	18.96	15.06	13.88	13.40
OPM %	21.13	19.43	20.62	20.67	22.81	26.31	22.21	20.80	19.68
Other Income	0.64	1.66	0.68	-2.56	0.96	0.16	0.87	0.21	0.15
Depreciation	4.69	4.75	4.67	4.66	4.64	4.69	4.51	4.60	4.60
Interest	6.00	4.25	5.06	5.15	6.29	6.28	5.90	6.32	9.45
Profit before tax	4.49	7.62	6.31	2.28	4.93	8.15	5.52	3.17	-0.50
Tax %	26.28	27.43	26.47	46.93	28.80	26.87	22.64	28.71	-28.00
Net Profit	3.31	5.53	4.63	1.21	3.51	5.96	4.28	2.26	-0.36
EPS in Rs	0.85	1.42	1.19	0.31	1.22	2.07	1.48	0.78	-0.13

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Sales	288.00	275.00	280.00	259.00	225.00	171.00	184.00
Expenses	228.00	215.00	223.00	206.00	173.00	133.00	147.00
Operating Profit	60.00	60.00	58.00	53.00	52.00	38.00	37.00
OPM %	21.00	22.00	21.00	20.00	23.00	22.00	20.00
Other Income	1.00	1.00	1.00	4.00	76.00	1.00	2.00
Interest	21.00	28.00	34.00	35.00	49.00	40.00	38.00
Depreciation	19.00	18.00	20.00	18.00	17.00	17.00	16.00
Profit before tax	21.00	15.00	5.00	3.00	62.00	-18.00	-15.00
Tax %	30.00	29.00	32.00	179.00	11.00	23.00	25.00
Net Profit	15.00	10.00	4.00	-2.00	55.00	-22.00	-19.00
EPS in Rs	3.83	3.64	1.35	-0.79	20.54	-8.14	-7.03
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Equity Capital	39.00	29.00	27.00	27.00	27.00	27.00	27.00
Reserves	181.00	68.00	39.00	36.00	36.00	-20.00	2.00
Borrowings	244.00	204.00	211.00	216.00	226.00	235.00	231.00
Other Liabilities	93.00	81.00	75.00	96.00	104.00	150.00	127.00
Total Liabilities	558.00	382.00	352.00	374.00	392.00	392.00	388.00
Fixed Assets	207.00	217.00	228.00	232.00	240.00	242.00	244.00
CWIP	82.00	7.00	0.00	9.00	0.00	0.00	0.00
Investments	7.00	8.00	4.00	0.00	3.00	2.00	0.00
Other Assets	262.00	150.00	120.00	133.00	149.00	149.00	144.00
Total Assets	558.00	382.00	352.00	374.00	392.00	392.00	388.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash from Operating Activity	48.00	47.00	58.00	43.00	62.00	31.00	38.00
Cash from Investing Activity	-94.00	-24.00	-10.00	-7.00	-6.00	-13.00	-9.00
Cash from Financing Activity	126.00	-23.00	-46.00	-42.00	-50.00	-18.00	-37.00
Net Cash Flow	81.00	-1.00	1.00	-6.00	6.00	0.00	-8.00
Free Cash Flow	-32.00	26.00	46.00	36.00	52.00	19.00	27.00
CFO/OP %	93.00	84.00	111.00	93.00	119.00	66.00	102.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Debtor Days	55.00	67.00	63.00	75.00	73.00	110.00	104.00
Inventory Days	530.00	464.00	309.00	247.00	338.00	422.00	225.00
Days Payable	230.00	194.00	129.00	130.00	185.00	186.00	99.00
Cash Conversion Cycle	354.00	336.00	243.00	193.00	226.00	345.00	229.00
Working Capital Days	6.00	26.00	16.00	42.00	28.00	-5.00	51.00
ROCE %	12.00	15.00	14.00	13.00	14.00	9.00	—

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025
Promoters	63.79	63.72	63.56	63.56
FIIs	0.43	0.85	1.10	1.00
DIIs	12.92	12.88	11.24	11.34
Public	22.84	22.55	24.09	24.10
No. of Shareholders	12,612	15,222	16,181	18,669

Corporate Actions

No corporate actions recorded.

Announcements

5 filings

Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
03 Sep 2026 3 Sep - Newspaper advertisement issued for special window on transfer and dematerialisation of physical shares.
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Amanta Healthcare Limited Announces Commissioning Of New Steriport Line
02 Sep 2026 2 Sep - Amanta Healthcare commissioned new SteriPort line at Kheda on September 2, 2026, boosting production and margins.
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 Aug 2026 25 Aug - Newspaper Advertisement for dispatch of Annual Report of the 31st Annual General Meeting and e-voting information
Intimation - Regulation 36(1)(B) Of The SEBI Listing Regulations
25 Aug 2026 25 Aug - 31st AGM on 16 September 2026; annual report web-link shared and KYC reminder issued.
Annual Report For Financial Year 2025-26
24 Aug 2026 24 Aug - Annual Report 2025-26 and 31st AGM notice; meeting on September 16, 2026 via VC/OAVM.